Chotosan ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia via activating the Nrf2-mediated antioxidant pathway.
J Pharmacol Sci. 2019 Feb;139(2):105-111. doi: 10.1016/j.jphs.2018.12.003. Epub 2018 Dec 22.
J Pharmacol Sci. 2019.
PMID: 30642751
Free article.
Recent studies suggested that Chotosan has ameliorative effects on vascular dementia through antioxidative pathways. ...Chotosan may serve as a potential candidate and promising Nrf2 activator for treating vascular dementia....
Recent studies suggested that Chotosan has ameliorative effects on vascular dementia through antioxidative pathways. ...Chotosan …